Beijing Strong Biotechnologies Inc (300406) — Capital Reinvestment Ratio
Beijing Strong Biotechnologies Inc (300406) has a Capital Reinvestment Ratio of 0.04x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥182.86 Million) in capital expenditures (CN¥7.23 Million). See 300406 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Beijing Strong Biotechnologies Inc Capital Reinvestment Ratio (2011–2024)
This chart tracks Beijing Strong Biotechnologies Inc's Capital Reinvestment Ratio across 14 annual periods.
Annual Capital Reinvestment Ratio for Beijing Strong Biotechnologies Inc (2011–2024)
Year-by-year Capital Reinvestment Ratio for Beijing Strong Biotechnologies Inc from 2011 to 2024. For live market cap and broader valuation context, see Beijing Strong Biotechnologies Inc stock valuation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.11x | CN¥614.01 Million | CN¥67.65 Million | ▼ -56.1% |
| 2023 | 0.25x | CN¥590.15 Million | CN¥148.03 Million | ▲ +3.0% |
| 2022 | 0.24x | CN¥396.17 Million | CN¥96.48 Million | ▲ +27.4% |
| 2021 | 0.19x | CN¥341.10 Million | CN¥65.20 Million | ▲ +36.4% |
| 2020 | 0.14x | CN¥123.06 Million | CN¥17.25 Million | ▼ -57.0% |
| 2019 | 0.33x | CN¥188.60 Million | CN¥61.41 Million | ▲ +14.1% |
| 2018 | 0.29x | CN¥256.15 Million | CN¥73.10 Million | ▲ +135.0% |
| 2017 | 0.12x | CN¥207.91 Million | CN¥25.25 Million | ▼ -61.5% |
| 2016 | 0.32x | CN¥243.21 Million | CN¥76.62 Million | ▼ -15.4% |
| 2015 | 0.37x | CN¥142.59 Million | CN¥53.08 Million | ▲ +751.3% |
| 2014 | 0.04x | CN¥156.94 Million | CN¥6.86 Million | ▼ -34.9% |
| 2013 | 0.07x | CN¥147.19 Million | CN¥9.89 Million | ▼ -58.7% |
| 2012 | 0.16x | CN¥125.49 Million | CN¥20.44 Million | ▼ -69.0% |
| 2011 | 0.53x | CN¥45.90 Million | CN¥24.13 Million | — |